Synthetic Biology
OpenAI’s GPT-Rosalind is a large language model tuned on common biology workflows and public databases, built to suggest pathways and prioritise drug targets. Citing bioweapon risk, OpenAI is limiting access to vetted US-based researchers for now.
WHY THIS MATTERS IN BRIEF Cellular amplification triples editing reach with lower doses, making systemic genetic treatments significantly more efficient…
WHY THIS MATTERS IN BRIEF We are seeing synthetic biology and AI converge, and the future could very well be…
WHY THIS MATTERS IN BRIEF The next frontier of computing isn’t silicon – in fact it’s everything but. Love…
WHY THIS MATTERS IN BRIEF When it comes to designing the code of life and new organisms AI’s increasingly on…
WHY THIS MATTERS IN BRIEF By combining genetically modified living tissue with brain machine interface technologies China’s BMI’s are seeing…
WHY THIS MATTERS IN BRIEF What’s the worst that could happen if you could trick a researcher into fabricating a…
WHY THIS MATTERS IN BRIEF There is a technology innovation arms race between the US and the West and China…
WHY THIS MATTERS IN BRIEF Technology research is pushing our understanding of the term “Robot” and now human cells have…
WHY THIS MATTERS IN BRIEF CRISPR is a world changing gene editing technology, and AI just found another 200 systems…
WHY THIS MATTERS IN BRIEF We are increasingly learning how to manipulate the code of life – DNA – and…
WHY THIS MATTERS IN BRIEF We’re building AI’s without understanding the risks, and when it comes to meddling with the…